Log in to save to my catalogue

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a8fd98b45fab417883bf96e9c8ffd705

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis

About this item

Full title

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2022-11, Vol.19 (1), p.268-13, Article 268

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The pathophysiology of sepsis may involve the activation of the NOD-type receptor containing the pyrin-3 domain (NLPR-3), mitochondrial and oxidative damages. One of the primary essential oxidation products is 8-oxoguanine (8-oxoG), and its accumulation in mitochondrial DNA (mtDNA) induces cell dysfunction and death, leading to the hypothesis that...

Alternative Titles

Full title

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a8fd98b45fab417883bf96e9c8ffd705

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a8fd98b45fab417883bf96e9c8ffd705

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-022-02616-6

How to access this item